Drugs / Split virion, inactivated Influenza vaccine
Split virion, inactivated Influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00718146 | Jun → Aug 2008 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Split virion, inactivated Influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00718146 ↗ |
| Modality | Vaccine | “Inactivated, Split-Virion Influenza Vaccine” NCT00718146 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular (IM)” NCT00718146 ↗ |